	Clinicopathological features ofÂ anaplastic lymphoma kinase-rearranged lung adenocarcinoma initially misdiagnosed with invasive mucinous adenocarcinoma - aÂ retrospective study. Pol J Pathol Dai X, Feng X, Lu Y, Peng F. PMID: 41549925 [PubMed - indexed for MEDLINE]
	Impact ofÂ age and histological type on programmed death-ligand 1 expression in non-small cell lung cancer - aÂ single-center analysis ofÂ 1,606 cases. Pol J Pathol Szumera-Cie, Wi, Tomczyk-Szatkowska A, Rosi, Pierzcha, Owczarek J, Winiarczyk K, Wo, Krzakowski M, Knetki-Wróblewska M. PMID: 41549924 [PubMed - indexed for MEDLINE]
	Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia: A Qualitative Focus Group Study. Health Expect Nicholls T, York S, Harrison NJ, Bartlett G, Troiani JP, Stanoevska B, Yap ML, Rhee J, Dodd RH, Marshall HM, McWilliams A, Stone E, Pitts L, Rankin NM. PMID: 41549621 [PubMed - indexed for MEDLINE]
	Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model. J Clin Lab Anal Zhang J, Liu S, Bai M, Ma F, Liang G, Wang B. PMID: 41549425 [PubMed - as supplied by publisher]
	Brain radiotherapy combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for advanced non-small cell lung cancer with brain metastases: a retrospective study. BMC Immunol Wu W, Zhong T, Zhou X, Chen W, Zhang X, Xu H, Tang Z, He W, Wang Y, Chen G, Wang Y, Liu B, Liu Y, Han Y, Lu K, Wang Y, Zhang B, Xiao L, Du Z, Liu Q, Liang J, Li X, Song L. PMID: 41549264 [PubMed - as supplied by publisher]
	Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis. BMC Cancer Feng Y, Qiao Y, Li H, Shen B, Ding J, Hua D. PMID: 41549245 [PubMed - as supplied by publisher]
	Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non-Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial. J Vasc Interv Radiol Liang C, Han D, Li H, Wang M, Kuang D, Chen H, Miao H, Chen P, Lu H, Jiao P, Ren J, Han X, Li F, Duan X. PMID: 41548595 [PubMed - as supplied by publisher]
	An evaluation of taletrectinib for the treatment of ROS1+ non-small cell lung cancer. Expert Rev Anticancer Ther Samaeekia R, Arter Z, Nagasaka M. PMID: 41548253 [PubMed - as supplied by publisher]
	The molecular key in exercise-induced lung cancer prevention: insights from Mendelian randomization and SULT1A1-mediated mechanisms. Eur J Med Res Zhu S, Chen Q, Huang C, Tang Z, Yang L, Xu X. PMID: 41547836 [PubMed - as supplied by publisher]
	Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer. J Transl Med Cavaliere S, Fogolari M, Iuliani M, Foderaro S, Cortellini A, Simonetti S, Mingo EC, Calagna S, Russano M, Vincenzi B, Tonini G, Angeletti S, Pantano F. PMID: 41547827 [PubMed - as supplied by publisher]
	PM2.5-modulated targets and miRNAs associated with lung cancer and injury are protected by natural products. Environ Pollut Chuang YT, Yen CY, Liu W, Chang FR, Tsai YH, Chan WH, Chien TM, Chang HW. PMID: 41547393 [PubMed - as supplied by publisher]
	Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark. Eur J Cancer Budolfsen T, Petersen RH, Møller LB, Brabrand J, Saghir Z, Quist M. PMID: 41547178 [PubMed - as supplied by publisher]
	Corrigendum to "Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial" [Radiother. Oncol. 208 (2025) 110907]. Radiother Oncol Dejonckheere CS, Nour Y, Sahlmann J, Engelhart MT, Hammi A, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller C, Schmid S, Miederer M, Brose A, Binder H, König J, Rimner A, Grosu AL, Nestle U, Gkika E. PMID: 41547133 [PubMed - as supplied by publisher]
	Efficacy of levosalbutamol for lung cancer patients receiving postoperative sputum expectoration by high-frequency chest wall oscillation. Pak J Pharm Sci Wang Y, Leng H. PMID: 41546583 [PubMed - indexed for MEDLINE]
	Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial. Trials De Lazzari N, Wiesweg M, Götte M, Franco J, Mincu RI, Jäger J, Huessler EM, Kuklik N, Stang A, Totzeck M, Tewes M. PMID: 41546104 [PubMed - as supplied by publisher]
	Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lungÂ cancer: a systematic review andÂ meta-analysis. BMC Cancer Zhang L, Jia H, Niu B. PMID: 41545863 [PubMed - as supplied by publisher]
	Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches - an umbrella review of meta-analyses. BMC Surg Xu Y, Han Q, Wang C, Xu J, Li X, Zhang Q. PMID: 41545856 [PubMed - as supplied by publisher]
	Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial. Signal Transduct Target Ther Wang M, Liu W, Guo H, Long H, Yu B, Zhao G, Wu J, Yue D, Zhao X, Li C, Zhang L, Wang S, Zhang Q, Zhang Z, Wang C. PMID: 41545337 [PubMed - indexed for MEDLINE]
	Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC. J Immunother Cancer Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I. PMID: 41545302 [PubMed - indexed for MEDLINE]
	Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models. Drug Discov Today Hossain NS, Tasnim N, Ferdoush J, Roy A, Saha SC, Saha A. PMID: 41544897 [PubMed - as supplied by publisher]

Articles 1 - 20 / 156547

Page 1 of 7828



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy